Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Can Urogen Pharma Urgn Stock Recover Now Urgn Q4 Earnings Misses Estimates By 0.03 20260410 1 Is Altisource Asps Stock Trading Above Fair Value Asps Q4 2025 Earnings Altisource Portfolio Solutions S.A. Posts 0.11 Eps 20260413 1 Is Citius Pharma Ctxr Stock Overvalued Now Price At 0.83 Up 5.07 20260408 Is Opendoor Technologies Open Stock Expanding Price At 4.61 Down 2.74 20260406 Is Universal UUU stock approaching trendline support Investor Interest 20260420 The stress test results at Enveric Biosciences ENVB Q4 2024 EPS Misses Views Viking Therapeutics VKTX Stock Is It in Consolidation Phase Q4 2025 Earnings Underperform Market Wrap SP 500 Drops as Tech Sector Leads Broad Losses Is Hooker HOFT stock attractive for portfolio addition Q1 2026 EPS Misses Views Is CantorEquity CEPF stock weaker than competitors BTCS Inc BTCS posts steep fourth quarter 2025 earnings miss yet stock notches slight gain in daily trading Is Vistance Networks VISN stock entering a consolidation phase Q4 2025 Below Expectations Vanguard Energy ETF VDE Positioned for Upside Amid Sustained Elevated Crude Price Regime Andy Burnham Seeks to Calm Markets with Fiscal Rule Commitment Jim Cramer Highlights GE Aerospaces CEOLed Turnaround Potential Steris STE Q4 2026 Earnings Transcript Released What Investors Should Know Waymo Recalls Thousands of Robotaxis After Creek Incident in Texas Wall Street Gains Ground as Chip Stocks Rally Ahead of Nvidia Earnings Anticipation CTGO Q1 2026 Earnings EPS Misses Estimates by a Wide Margin as Operational Challenges Persist Teo Siong Seng Shipping Scion Under Scrutiny Over Container Price Fixing Allegations Bessent Sees Substantial Disinflation Ahead as Warsh Takes Over Fed NewtekOne Inc NEWT Q1 2026 Earnings Earnings Miss but Stock Climbs on Optimism Cactus Inc Q1 2026 Earnings EPS Beats Estimates by 86 as Operational Efficiency Shines AMWL Q1 2026 Earnings EPS Beats Estimates by Wide Margin as Cost Controls Drive Improvement PAR Technology Q1 2026 Earnings EPS Surges Past Estimates Stock Moves Higher SBLK Q1 2026 Earnings EPS Surges Past Estimates Stock Declines SCHMID Group Warrants SHMDW Surge 849 Key Support and Resistance in Focus Japer Therapeutics Warrants JSPRW Remain Under Pressure at Penny Level Medtronic MDT Slides 1 as Markets Weigh Growth Prospects Key Support in View 1st Source Corporation SRCE Edges Higher Testing Key Technical Levels